Biolegend, 400112, PE Mouse IgG1, κ Isotype Ctrl Antibody, 100μg

The MOPC-21 immunoglobulin has unknown specificity. The isotype of this antibody is mouse IgG1, κ. This antibody was chosen as an isotype control after screening on a variety of resting, activated, live, and fixed mouse, rat and human tissues.
100μg
Antibody Type: Monoclonal
Host Species: Mouse
Formulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation: The immunoglobulin was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration: 0.2 mg/ml
Storage & Handling: The IgG1, κ isotype control solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application: FC - Quality tested ICFC - Verified
Recommended Usage: Each lot of this mouse IgG1, κ isotype control antibody is quality control tested by immunofluorescent staining with flow cytometric analysis as negative control. Use at concentrations comparable to those of the specific antibody of interest. Use our Concentration Lookup tool to find the exact concentrations of your lots of product.
Excitation Laser: Blue Laser (488 nm)Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes: Additional reported applications (for the relevant formats) include: Intracellular Flow Cytometry (ICFC), Immunocytochemistry (ICC), Immunohistochemistry (IHC), Immunoprecipitation (IP), Western Blotting (WB), Functional Assay (FA)
Application References(PubMed link indicates BioLegend citation): Carlsten M, et al. 2007. Cancer Res. 67:1317. PubMed Smed-Sörensen A, et al. 2008. Blood 111:5037. PubMed (FA) Bunesmann MM, et al. 2011. Am. J. Respir. Cell. Mol. Biol. Epub. PubMed Matsuyama T, et al. 2005. Infect. Immun. 73:1044. (IF) Correia DV, et al. 2011. Blood 118:992. (FC) PubMed Lian IA, et al. 2011. Placenta. 32:823. PubMed Bufe B, et al. 20015. J Biol Chem. 290:7369. PubMed
Product Citations: Braun F, et al. 2015. PLoS One. 10:117994. PubMed Xin Y, et al. 2021. Stem Cell Res Ther. 49:12. PubMed Silva ATF, et al. 2022. Int J Mol Sci. 23:. PubMed Ciftci Dede E, et al. 2023. PLoS One. 18:e0282238. PubMed Hu X, et al. 2023. Nat Biotechnol. . PubMed Jacquot P, et al. 2023. Biomolecules. 13:. PubMed Yen FC, et al. 2023. Nat Commun. 14:2942. PubMed Park J, et al. 2021. Exp Ther Med. 22:808. PubMed Shao L, et al. 2021. Cell Death Discov. 7:145. PubMed Yamin R, et al. 2021. Nature. 599:465. PubMed Tocheva AS, et al. 2020. Curr Protoc Immunol. 130:e103. PubMed Garcia-Larragoiti N, et al. 2021. J Thromb Haemost. 19:2572. PubMed Merah-Mourah F, et al. 2021. Curr Protoc. 1:e229. PubMed Li L, et al. 2022. FEBS J. 289:2877. PubMed Kemble S, et al. 2022. Blood Adv. 6:2932. PubMed Connor T, et al. 2022. Methods Mol Biol. 2475:47. PubMed Kuczynski EA, et al. 2022. EMBO Mol Med. 14:e15816. PubMed Jo S, et al. 2023. J Bone Miner Res. 38:300. PubMed Cano-Mendez A, et al. 2022. Int J Mol Sci. 23: . PubMed Gerace D, et al. 2023. Cell Rep Med. 4:100879. PubMed Iancu O, et al. 2023. Mol Ther Nucleic Acids. 31:105. PubMed Vondra S, et al. 2023. Cell Rep. 42:111977. PubMed Cao B, et al. 2022. Nat Commun. 13:6203. PubMed Lokmic Z, et al. 2015. J Vis Exp. 99: 52691. PubMed Ameres S, et al. 2014. J Immunol. 192:5894. PubMed Lee JK, et al. 2020. Sci Rep. 2.567361111. PubMed Fielding CA et al. 2017. eLife. 6 pii: e22206. PubMed Banks DA, et al. 2019. J Immunol. 202:2348. PubMed Kitagawa S, et al. 2022. NPJ Vaccines. 7:115. PubMed Dam T, et al. 2021. Front Physiol. 11:613367. PubMed Grayson KA, et al. 2021. Mol Cancer Ther. 20:833. PubMed Figueroa-Romero C, et al. 2022. Front Immunol. 13:773288. PubMed Sim J, et al. 2019. MAbs. 11:1036. PubMed Shokri MR, et al. 2019. Sci Rep. 9:10007. PubMed Meng KP, et al. 2020. J Exp Med. 217:00:00. PubMed Junghans V, et al. 2020. J Cell Sci. 133:00:00. PubMed Gadkari M, et al. 2018. Sci Data. 5:180275. PubMed Shimizu S, et al. 2022. Pharmacol Res Perspect. 10:e00933. PubMed Beatson RE, et al. 2021. Cell Rep Med. 2:100473. PubMed Sugita S, et al. 2016. Stem Cell Reports. 7:619-634. PubMed Tuttle KD, et al. 2020. Cell Rep. 33:108407. PubMed Iwabuchi R, et al. 2021. Frontiers in Immunology. 12:643040. PubMed Wu Y, et al. 2019. Sci Rep. 9:20301. PubMed Gui J, et al. 2020. Nat Cancer. 1:603. PubMed Liu S, et al. 2021. Mol Ther Oncolytics. 21:303. PubMed Perelman SS, et al. 2021. Nat Microbiol. 6:731. PubMed Zoldan K, et al. 2014. Dev Comp Immunol. 47:254. PubMed Karagianni AE, et al. 2021. Sci Rep. 11:14292. PubMed Schatzlmaier P, et al. 2015. Sci Signal. 8: rs11. PubMed Liang Y, et al. 2019. J Allergy Clin Immunol. 144:1025. PubMed Grandclaudon M, et al. 2019. Cell. 179:432. PubMed Sahillioglu AC, et al. 2021. Cancer Immunol Res. 9:999. PubMed Mulas F, et al. 2020. Cell Mol Immunol. . PubMed Stephens M, et al. 2021. Sci Rep. 1.385416667. PubMed Yamada S, et al. 2021. J Tissue Eng. 12:20417314211019375. PubMed Mendoza-Cabrera MI, et al. 2019. Innate Immun. :1753425919864658. PubMed Luo Y, et al. 2021. Nat Commun. 12:3913. PubMed Hopf A, et al. 2022. Bioengineering (Basel). 9:. PubMed OConnor RA, et al. 2021. OncoImmunology. 10(1):1940675. PubMed Foltz L, et al. 2020. Mol Biol Cell. 31:2269. PubMed Foight GW, et al. 2019. Nat Biotechnol. 37:1209. PubMed Chen S, et al. 2019. Am J Physiol Lung Cell Mol Physiol. 316:L280. PubMed Nam GH, et al. 2018. Nat Commun. 9:2165. PubMed Soto-Pantoja DR, et al. 2021. Cancer Res. 81:3890. PubMed Peng H, et al. 2020. Ann Transl Med. 0.927777778. PubMed Sikder S, et al. 2020. J Leukoc Biol. 107:263. PubMed Wright A, et al. 2016. J Immunol. 196: 4877 - 4884. PubMed Hofmann L, et al. 2022. Front Med (Lausanne). 9:904295. PubMed Majedi FS, et al. 2020. Biomaterials. 252:120058. PubMed Lehrke MJ, et al. 2021. Elife. 10:. PubMed Shibuya M, et al. 2021. iScience. 24:103131. PubMed Mohammadi MR, et al. 2021. Commun Biol. 4:685. PubMed Huang X, et al. 2015. PLoS One. 10: 0133152. PubMed Dent JR, et al. 2019. J Appl Physiol (1985). 127:1117. PubMed Wang F, et al. 2018. Oncogene. 37:286. PubMed Ray JE, et al. 2021. Cancer Biol Ther. 22:554. PubMed Vogel A, et al. 2022. Cell Rep. 38:110420. PubMed Tian R, et al. 2020. Genes (Basel). :11. PubMed Deng Z, et al. 2021. Mol Med Rep. :23. PubMed Fei D, et al. 2021. Front Cell Dev Biol. 9:687258. PubMed Song S, et al. 2021. Front Immunol. 12:705140. PubMed Loo Yau H, et al. 2021. STAR Protocols. 2(2):100549. PubMed Srivastava S, et al. 2020. Cancer Cell. 39(2):193-208.e10. PubMed Zhang HC, et al. 2018. Int J Mol Med. 41:13. PubMed Vonderhaar EP, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:41. PubMed Tomita T, et al. 2021. Nat Commun. 12:3655. PubMed Bassaganyas L, et al. 2019. J Cell Biol. 218:3861. PubMed Shiba T, et al. 2019. J Allergy Clin Immunol. 144:1438. PubMed Kawamoto E, et al. 2021. Biomedicines. 9:. PubMed Liang YH, et al. 2021. J Biomed Sci. 28:75. PubMed Ishii Y, et al. 2021. J Biol Chem. 297:101223. PubMed Sharari S, et al. 2022. Front Endocrinol (Lausanne). 13:841788. PubMed Samuel RM, et al. 2020. Cell Stem Cell. 27:876. PubMed Chew G, et al. 2016. PLoS Pathog. 12: 1005349. PubMed Robinet P, et al. 2014. J Immunol. 192:5332. PubMed Anderson NR, et al. 2019. Cell Adh Migr. 13:163. PubMed Akhtar MN, et al. 2020. PLoS Pathog. 16:e1009136. PubMed
RRID: AB_2847829 (BioLegend Cat. No. 400111) AB_2847829 (BioLegend Cat. No. 400112)
Gene ID: NA
Clone: MOPC-21
Regulatory Status: RUO
Isotype: Mouse IgG1, κ
Q: What type of PE do you use in your conjugates?
A: We use R-PE in our conjugates.